XML 27 R13.htm IDEA: XBRL DOCUMENT v3.25.1
GOODWILL AND OTHER INTANGIBLE ASSETS, NET
 3 Months Ended
Mar. 31, 2025
Goodwill and Intangible Assets Disclosure [Abstract]  
GOODWILL AND OTHER INTANGIBLE ASSETS, NET GOODWILL AND OTHER INTANGIBLE ASSETS, NET
Goodwill
The following is a reconciliation of goodwill by segment.
(in millions)Medical Products & TherapiesHealthcare Systems & TechnologiesPharmaceuticalsTotal
Balance as of December 31, 2024$1,185 $3,550 $540 $5,275 
Currency translation 38 8 17 63 
Balance as of March 31, 2025$1,223 $3,558 $557 $5,338 
Other intangible assets, net
The following is a summary of our other intangible assets.
Indefinite-lived intangible assets
(in millions)Customer relationshipsDeveloped technology, including patentsTrade namesOther amortized intangible assetsTrade namesIn process Research and Development
Total
December 31, 2024
Gross other intangible assets$3,387 $3,131 $958 $86 $680 $107 $8,349 
Accumulated amortization(878)(2,075)(107)(66)— — (3,126)
Other intangible assets, net$2,509 1,056 851 20 680 107 5,223 
March 31, 2025
Gross other intangible assets$3,389 $3,154 $953 $88 $680 $107 $8,371 
Accumulated amortization(932)(2,170)(119)(69)— — (3,290)
Other intangible assets, net$2,457 $984 $834 $19 $680 $107 $5,081 
Intangible asset amortization expense was $155 million and $158 million for the three months ended March 31, 2025 and 2024, respectively